SILEXION THERAPEUTICS CORP Foreign Currency Transaction Gain (Loss), before Tax
SILEXION THERAPEUTICS CORP (SLXN) reported Foreign Currency Transaction Gain (Loss), before Tax of $40.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $40.00K, a 34.43% decline year-over-year.
- SILEXION THERAPEUTICS CORP foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $27.00K.
- SILEXION THERAPEUTICS CORP foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $40.00K, a 21.57% decline year-over-year.
- SILEXION THERAPEUTICS CORP foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $32.00K, a 33.33% decline year-over-year.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $40.00K 10-Q · filed 2026-08-14 | $67.00K 10-Q · filed 2026-08-14 | $107.00K derived: sum of 3 quarters · filed 2026-08-14 | $139.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $27.00K S-1/A · filed 2026-08-10 | $67.00K derived: sum of 2 quarters · filed 2026-08-10 | $99.00K derived: sum of 3 quarters · filed 2026-08-10 | $160.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $40.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $72.00K derived: sum of 2 quarters · filed 2026-08-10 | $133.00K derived: sum of 3 quarters · filed 2026-08-14 | $127.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | $32.00K 10-Q · filed 2025-11-12 | $93.00K derived: sum of 2 quarters · filed 2026-08-14 | $87.00K 10-Q · filed 2025-11-12 | $138.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $61.00K 10-Q · filed 2026-08-14 | $55.00K 10-Q · filed 2026-08-14 | $106.00K derived: sum of 3 quarters · filed 2026-08-14 | $154.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$6.00K S-1/A · filed 2026-08-10 | $45.00K derived: sum of 2 quarters · filed 2026-08-10 | $93.00K derived: sum of 3 quarters · filed 2026-08-10 | $135.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | $51.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $99.00K derived: sum of 2 quarters · filed 2026-08-10 | $141.00K derived: sum of 3 quarters · filed 2026-08-10 | $247.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | $48.00K 10-Q · filed 2025-11-12 | $90.00K derived: sum of 2 quarters · filed 2025-11-12 | $196.00K 10-Q · filed 2025-11-12 | $129.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $42.00K 10-Q · filed 2025-08-12 | $148.00K 10-Q · filed 2025-08-12 | $81.00K derived: sum of 3 quarters · filed 2025-08-20 | $150.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2024-03-31 | $106.00K 10-Q · filed 2025-05-13 | $39.00K derived: sum of 2 quarters · filed 2025-08-20 | $108.00K derived: sum of 3 quarters · filed 2025-08-20 | $595.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2023-12-31 | -$67.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | $2.00K derived: sum of 2 quarters · filed 2025-08-20 | $489.00K derived: sum of 3 quarters · filed 2025-08-20 | $453.00K 8-K · filed 2025-08-20 |
| 2023-09-30 | $69.00K 10-Q · filed 2024-11-14 | $556.00K derived: sum of 2 quarters · filed 2024-11-14 | $520.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $487.00K 10-Q · filed 2024-08-29 | $451.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |